Cite
Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR.
MLA
Li, Tao, et al. “Prognostic Value of CYFRA 21 − 1 and Ki67 in Advanced NSCLC Patients with Wild-Type EGFR.” BMC Cancer, vol. 23, no. 1, Mar. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12885-023-10767-9.
APA
Li, T., Xie, Q., Fang, Y.-Y., Sun, Y., Wang, X. M., Luo, Z., Yan, G.-L., He, J.-B., & Zheng, X.-Q. (2023). Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR. BMC Cancer, 23(1), 1–10. https://doi.org/10.1186/s12885-023-10767-9
Chicago
Li, Tao, Qi Xie, Yang-Yang Fang, Yi Sun, Xiao Ming Wang, Zhu Luo, Gui-Ling Yan, Jian-Bo He, and Xiao-Qun Zheng. 2023. “Prognostic Value of CYFRA 21 − 1 and Ki67 in Advanced NSCLC Patients with Wild-Type EGFR.” BMC Cancer 23 (1): 1–10. doi:10.1186/s12885-023-10767-9.